Asher Biotherapeutics
CA - South SFBiotechnology
Focus: Asher Biotherapeutics is a small-scale biotechnology company focused on IL-2 therapies for immunology indications. With 1-50 employees and public status, the company operates as a specialized immunology-focused biotech player.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Employees
1-50
Open Jobs
0
About Asher Biotherapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Asher Biotherapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
AB821
Advanced MelanomaClinical Trials (1)
NCT07027488AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1Help build intelligence for Asher Biotherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.